James S. Hagood, MD, professor in the UNC Department of Pediatrics and Director of the Program for Rare and Interstitial Lung Disease of the UNC Children’s Research Institute and Marsico Lung Institute, has been selected as a Harrington Scholar-Innovator for his work on a therapeutic Strategy for pulmonary fibrosis. James S. Hagood, MD, professor in … Read more

Matthew Vogt, MD, PhD, and Michelle Hernandez, MD, initiate pandemic preparedness study focused on children with NIAID Vaccine Research Center. The Pandemic Response Repository Through Microbial and Immunological Surveillance and Epidemiology (PREMISE) initiative is enrolling children aged 10 years or younger in a study aimed at getting ahead of the next pandemic. By studying the … Read more

The study outlines the main drivers of parent hesitancy as perceived safety and efficacy of the vaccines and lower severity of illness in children. Many vaccine-hesitant parents may be open to vaccination in the future and welcome additional discussion and data, the researchers found. A study published last month in Parent Education and Counseling outlines that the … Read more

Matthew Laughon, MD, MPH, professor of pediatrics at the UNC School of Medicine, led UNC’s site for a national clinical trial that compared the use of hydrocortisone versus placebo for preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive. A study published in the New England Journal of Medicine concludes that hydrocortisone … Read more

Matthew Vogt, MD, PhD, was awarded an R01 from NIAID to generate new monoclonal antibodies in hopes of informing pan-enterovirus vaccines. Matthew Vogt, MD, PhD, assistant professor of Pediatrics in the Division of Infectious Diseases and of Microbiology & Immunology, has been granted an R01 from the National Institute of Allergy and Infectious Diseases (NIAID). The 5-year, $3.14 … Read more